Published November 6, 2023 | Version v2
Dataset Open

NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy

Creators

  • 1. ROR icon Instituto Murciano de Investigación Biosanitaria
  • 2. Hematology and Medical Oncology Department, Hospital Universitario Morales-Meseguer, Centro Regional de Hemodonación, Murcia, Spain
  • 3. CIBERER CB15/00055 (U765)
  • 4. ROR icon Universidad Católica San Antonio de Murcia
  • 5. Universidad de Murcia

Files

Files (57.5 kB)

Name Size Download all
md5:8e49cbb8d414210d90bcc6d3acddd67d
57.5 kB Download